Angela W Kim, MD
Ophthalmology · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kim’s office at (559) 448-4500 to ask if they take your plan before you enroll.
State licence records
1 licence
- Texas L8396Physician License · since 2004 · expires 2026-11-30ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Original Medicare doctor bills
$39,428
Medicare paid this office $39,428 for 144 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 48 | $3,980 | $83 |
| Long return visit (40+ min) | 24 | $3,527 | $126 |
| Established patient problem focused exam of visual system | 45 | $3,283 | $59 |
| Exam of visual field with extended testing | 31 | $1,508 | $46 |
| Short return visit (20+ min) | 22 | $1,450 | $60 |
See all 7 services
| Return visit (30+ min) | 48 | $3,980 | $83 |
| Long return visit (40+ min) | 24 | $3,527 | $126 |
| Established patient problem focused exam of visual system | 45 | $3,283 | $59 |
| Exam of visual field with extended testing | 31 | $1,508 | $46 |
| Short return visit (20+ min) | 22 | $1,450 | $60 |
| Photography of content of eyes | 35 | $570 | $15 |
| Imaging of optic nerve | 11 | $283 | $24 |
Who their Medicare patients are
144 Original Medicare patients in 2024. Average age 73 · Women 60% · Also on Medicaid 20% · Health risk score 1.85. Sicker patients than 9 in 10 peers; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 75% · Diabetes 44% · Chronic kidney disease 35% · Coronary heart disease 31% · Depression 19% · Atrial fibrillation 16% · Heart failure 14% · COPD 12% · Cancer 10% · Stroke 10%.
The office billed $170,683, Medicare allowed $52,818 and paid $39,428; for 1,184 services of 51 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 144 | 1,184 | 73 | 1.85 | $170,683 | $39,428 |
| 2023 | 98 | 517 | 72 | 1.49 | $73,676 | $20,628 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Long return visit (40+ min) | 43 | $6,152 | $137 |
| Return visit (30+ min) | 22 | $2,633 | $98 |
| Established patient problem focused exam of visual system | 17 | $1,231 | $68 |
| Photography of content of eyes | 12 | $209 | $17 |
Drugs they prescribed that Part D paid
$35,546
Pharmacies billed $35,546 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
145 generic and 102 brand-name prescriptions · $35,546 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Restasis | 13 | $14,553 | $1,119 |
| Neomycin-Polymyxin-Dexameth | 96 | $1,284 | $13 |
| Prednisolone Acetate | 13 | $611 | $47 |
| Moxifloxacin | 14 | $572 | $41 |
| Latanoprost | 18 | $247 | $14 |
Year by year
| 2024 | 247 | 101 | None | 41% | $35,546 |
| 2023 | 101 | 56 | 0% (0) | 26% | $5,608 |
| 2022 | 56 | 28 | 0% (0) | None | $2,231 |
| 2021 | 11 | None | 0% (0) | None | $357 |
| 2020 | 25 | 16 | 0% (0) | None | $1,782 |
| 2019 | 75 | 43 | 0% (0) | 20% | $5,039 |
| 2018 | 64 | 45 | 0% (0) | 23% | $5,028 |
| 2017 | 23 | 14 | 0% (0) | None | $2,104 |
| 2015 | 12 | None | None | None | $674 |
| 2014 | 75 | 55 | None | 15% | $5,049 |
| 2013 | 274 | 184 | None | 10% | $10,100 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Neomycin-Polymyxin-Dexameth | 29 | $548 | $19 |
| Latanoprost | 17 | $266 | $16 |
2022: 2 drugs
| Dorzolamide-Timolol | 15 | $356 | $24 |
| Latanoprost | 16 | $257 | $16 |
2019: 1 drug
| Erythromycin | 18 | $386 | $21 |
2018: 1 drug
| Erythromycin | 19 | $328 | $17 |
2014: 2 drugs
| Bacitracin | 29 | $2,001 | $69 |
| Polymyxin B Sul-Trimethoprim | 13 | $122 | $9 |
2013: 6 drugs
| Restasis | 12 | $3,594 | $300 |
| Bacitracin | 28 | $1,749 | $62 |
| Bacitracin-Polymyxin | 59 | $1,570 | $27 |
| Polymyxin B Sul-Trimethoprim | 53 | $554 | $10 |
| Latanoprost | 13 | $275 | $21 |
| Lorazepam | 43 | $233 | $5 |
Money from drug and device companies
$130 in 2025
| 2025 | 1 | 1 | None | $130 |
| 2024 | 1 | 1 | None | $75 |
| 2020 | 1 | 1 | None | $14 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Revance Therapeutics | Daxxify | $130 | 1 payment
|
See the published payment
| Revance Therapeutics | Meals · 2025-02-17 | Daxxify | $130 |
See earlier years (2024, 2020)
2024: $75
| Amgen | Uplizna | $75 | 1 payment
|
2020: $14
| Davol | None | $14 | 1 payment
|
Professional record
- NPI
- 1841206554
- Licence
- TX L8396Texas L8396: Active
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207WX0109X (207WX0109X)
- Mailing address
- 8300 Floyd Curl Dr, San Antonio, TX, 78229
- NPI first listed
- 2006-08-01
- NPI last updated
- 2023-09-06
- NPI record certified
- 2023-09-06
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305
This office lists an electronic records connection.